Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad de Salamanca
Original Assignee
Universidad de Salamanca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad de SalamancafiledCriticalUniversidad de Salamanca
Priority to ES200000960ApriorityCriticalpatent/ES2173023B1/es
Publication of ES2173023A1publicationCriticalpatent/ES2173023A1/es
Application grantedgrantedCritical
Publication of ES2173023B1publicationCriticalpatent/ES2173023B1/es
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Peptides Or Proteins
(AREA)
Abstract
La composición farmacéutica comprende una o más proteínas aisladas de garrapatas del género ornithodoros con actividad inmunosupresora junto con un excipiente farmacéuticamente aceptable. La composición farmacéutica es adecuada para prevenir y tratar el rechazo del injerto en transplantes y para tratar enfermedades autoinmunes y patologías alérgicas.
ES200000960A2000-04-122000-04-12Composicion farmaceutica con actividad inmunosupresora
Expired - Fee RelatedES2173023B1
(es)
composto e/ou um seu sal ou estereoisÈmero farmaceuticamente aceitável, processo para preparar e uso do mesmo, composição farmacêutica, e, kit farmacêutico